Randomized Trial: Treatments for Metastatic Nonsquamous NSCLC Compared
15 Jun, 2018 | 01:16h | UTCAtezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: ASCO 2018: First-Line Atezolizumab Improves Survival in Advanced NSCLC – European Society of Medical Oncology (free)